The temptation to use uncontrolled, early, small studies to support further development of products may prove problematic for emerging biopharma companies.
Phillip Ward
Advertisement
Phillip Ward is the European editor of Applied Clinical Trails.
Articles by Phillip Ward
Applied Clinical Trials
Synexus has announced plans to open three new research centers in Bulgaria, Poland and Romania.
Applied Clinical Trials
Significant differences exist in the characteristics of the priority review drugs approved by the FDA and the European Medicines Agency.
Advertisement
Latest Updated Articles
- Small Biopharm Firms Struggle to Meet Development Challenges
February 2nd 2017
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
Breaking the Efficacy Ceiling in IBD and Beyond
5